Rationale and design of the OACIS-LIPID study that evaluates early use of pravastatin in acute myocardial infarction

HeartDrug

Volumn 5, Issue 4, 2005, Pages 193-196

  Sakata, Yasuhiko ^a   Sato, Hiroshi ^a   Kinjo, Kunihiro ^a   Fujii, Kenshi ^b   Kodama, Kazuhisa ^c   Tanouchi, Jun ^e   Mishima, Masayoshi ^f   Kusuoka, Hideo ^d   Nakatani, Daisaku ^a   Mizuno, Hiroya ^a   Shimizu, Masahiko ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sakurabashi Watanabe Hospital   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

^e OSAKA ROSAI HOSPITAL   (Japan)

^f KAWACHI GENERAL HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Statin

Indexed keywords

AMINOTRANSFERASE; CREATINE KINASE; PRAVASTATIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; HYPERLIPIDEMIA; JAPAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOPATHY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SIDE EFFECT; STANDARDIZATION;

EID: 29144433349     PISSN: 14229528     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089599     Document Type: Article

References (12)

1. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-1357.
2. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.
3. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
4. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996;335:1001-1009.
5. Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, Mehta RH, Brieger D; GRACE Investigators: Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 2004;140:857-866.
6. Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F, Schultheiss HP: Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event [the randomized Lipid-Coronary Artery Disease (L-CAD) Study]. Am J Cardiol 2000;86:1293-1298.
7. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
8. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-1718.
9. Thompson PL, Meredith I, Amerena J, Campbell TJ, Sloman JG, Harris PJ; Pravastatin in Acute Coronary Treatment (PACT) Investigators: Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J 2004;148:e2.
10. Kinjo K, Sato H, Sato H, Shiotani I, Kurotobi T, Ohnishi Y, Hishida E, Nakatani H, Ito Y, Koretsune A, Hirayama, J, Tanouchi M, Mishima T, Kuzuya H, Takeda D, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS) Group: Circadian variation of the onset of acute myocardial infarction in the Osaka area, 1998-1999: characterization of morning and nighttime peaks. Jpn Circ J 2001;65:617-620.
11. Ohnishi Y, Tanaka T, Yamada R, Suematsu K, Minami M, Fujii K, Hoki N, Kodama K, Nagata S, Hayashi T, et al: Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population. Hum Genet 2000;106:288-292.
12. Kinjo K, Sato H, Sakata Y, Nakatani D, Mizuno H, Shimizu M, Nishino M, Ito H, Tanouchi J, Nanto S, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS) Group: Relation of C-reactive protein and 1-year survival after acute myocardial infarction with vs without statin therapy. Am J Cardiol 2005;96:617-621.